We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Event Schedule

Tuesday, November 17, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Women and the heart: are we missing cardiovascular risk?
Dr Roger Henderson GP and Health Broadcaster
Dr Gaby Captur Consultant Cardiologist, Clinical Lead Inherited Cardiac Conditions , Royal Free London
10:40 AM - 11:25 AM
Sponsored session – details coming soon (Respiratory)
12:40 PM - 1:25 PM
Sponsored session – details coming soon (Migraine)
1:40 PM - 2:25 PM
Is there a role for probiotics alongside antibiotics?
  • Understand the role of the gut microbiome and the impact of antibiotics
  •  Identify strategies to support the gut microbiome during and after antibiotics, including the role of probiotics
  •  Explore new research investigating the impact of probiotics on antibiotic-induced dysbiosis
Professor Simon Gaisford Vice-Dean (Impact & External Engagement) for the Faculty of Life Sciences and Chair in Pharmaceutics , University College London

This session is sponsored by Symprove

2:40 PM - 3:25 PM
Sponsored session – details coming soon (Cancer)
3:30 PM - 4:15 PM
Illness anxiety disorder
  • Clinical features and risk factors
  • Diagnostic criteria
  • Differential diagnosis and evidence-based management
Dr Roger Henderson GP and Health Broadcaster
4:15 PM
Conference ends
Wednesday, November 18, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Type 2 Diabetes: Beyond HbA1c
Dr Thomas Round GP Bromley by Bow Health, NIHR Academic Clinical Lecturer
10:40 AM - 11:25 AM
Heart failure and AF: spotting the connection and getting the management right
11:40 AM - 12:25 PM
Sponsored session – details coming soon (Migraine)
12:40 PM - 1:25 PM
Pharmacological management of ADHD in primary care
  • Compare pharmacological and non-pharmacological interventions for children and adults, incorporating NICE recommended medication pathways and evidence-based environmental modifications
  • Apply clinical evidence to understand common misconceptions regarding ADHD pharmacotherapy, and consider the concerns of wary patients, parents, and caregivers to support informed decision-making
  • Consider how to integrate a standardised approach between primary and secondary care for the maintenance and monitoring of ADHD treatment including symptom rating, and adherence strategies
Lesley Soffe Clinical Nurse Educator
Mark Pitts Clinical Nurse Educator

This session was initiated and funded by Takeda UK Ltd. Takeda medicines may be mentioned in this presentation.

1:40 PM - 2:25 PM
Session details coming soon
2:40 PM - 3:25 PM
Parkinsons Disease: Past, Present, Future
  • A brief review of the history of Parkinson's Disease
  • A look at how we support our patients living with Parkinson's Disease now
  • A glance at what the future of Parkinson's Disease management might be
Dr Alistair Church GP Principal and Consultant Neurologist with an interest in movement disorder
3:25 PM
Conference ends

10 CPD hours

Speakers

Dr Roger Henderson
Dr Roger Henderson
GP and Health Broadcaster
Mark Pitts
Mark Pitts
Clinical Nurse Educator
Lesley Soffe
Lesley Soffe
Clinical Nurse Educator
Dr Thomas Round
Dr Thomas Round
GP Bromley by Bow Health, NIHR Academic Clinical Lecturer
Dr Gaby Captur
Dr Gaby Captur
Consultant Cardiologist, Clinical Lead Inherited Cardiac Conditions
Dr Alistair Church
Dr Alistair Church
GP Principal and Consultant Neurologist with an interest in movement disorder
Professor Simon Gaisford
Professor Simon Gaisford
Vice-Dean (Impact & External Engagement) for the Faculty of Life Sciences and Chair in Pharmaceutics